Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal (Q33400612)

26 July 2017

Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal (English)

1 reference

26 July 2017

1 reference

Dwayne Boyers

1

1 reference

26 July 2017

Xueli Jia

series ordinal

2

1 reference

26 July 2017

David Jenkinson

series ordinal

3

1 reference

26 July 2017

Graham Mowatt

series ordinal

4

1 reference

26 July 2017

1 June 2012

1 reference

26 July 2017

1 reference

26 July 2017

30

1 reference

26 July 2017

6

1 reference

26 July 2017

483-495

1 reference

https://scigraph.springernature.com/pub.10.2165/11591550-000000000-00000

26 July 2017

0 references

cites work

Single technology appraisal at the UK National Institute for Health and clinical excellence: a source of evidence and analysis for decision making internationally

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing chemotherapy: a NICE single technology appraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip or knee surgery: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Golimumab for the treatment of psoriatic arthritis: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

The estimation of a preference-based measure of health from the SF-36.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591550-000000000-00000

Pazopanib for the first-line treatment of patients with advanced and/or metastatic renal cell carcinoma : a NICE single technology appraisal

21 January 2018

1 reference

12 December 2020

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal

1 reference

12 December 2020

Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization : a NICE single technology appraisal

1 reference

12 December 2020

Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses

1 reference

12 December 2020

Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal

1 reference

12 December 2020

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology

1 reference

12 December 2020

10.2165/11591550-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference